{"id":"n_gxlyph6yblx23rm3m2eq","seq":10829928,"kind":"article","title":"FDA approves durvalumab with enfortumab vedotin-ejfv for muscle invasive bladder cancer","url":"http://www.fda.gov/drugs/cancer-approvals/fda-approves-durvalumab-enfortumab-vedotin-ejfv-muscle-invasive-bladder-cancer","published":"2026-11-13T18:22:19Z","seen":"2026-11-13T19:32:53Z","lang":"en","country":"US","source":{"id":"kite-fda-gov-272311","name":"fda.gov","domain":"fda.gov"},"via":"kite-fda-gov-272311","topics":["healthcare","usa"],"authors":["FDA"],"story":"st_gxlyph6yblx23rm3m2eq","category":"health","category_p":0.46,"sentiment":"neutral","tone":0.19,"political":0.19}